Current stock page

Catalysts

PACB Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

PACBPacific Biosciences of California, Inc.

Healthcare / Medical - Devices

Low Priority

In Line With Peers

BearishEdge 4/10
$1.83+$0.01 (+0.55%)

Latest quote

  • Momentum
    84
  • Value
    23
  • Quality
    32
  • Risk resilience
    24
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 9, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 48/100

Momentum 84/100 and sentiment — before the next covered event.

Recent coverage
2 articles

Updated Nov 18, 2026 · Sentiment 6.25%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 84/100AIQ Edge 4/10 In Line With Peers
Beat rate
63%
5 of 8 reported periods
Average surprise
-59.6%
Across covered historical reports
Latest result
+18.2%
Nov 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—-$0.13-$0.11+18.2%$39.31M$40.56M
Aug 5, 2026—-$0.14-$0.14+0.0%$39.93M$39.01M
Aug 3, 2026—-$0.13-$0.14-9.4%$42.9M$39.01M
May 7, 2026—-$0.17-$0.03+82.4%$39.94M$37.18M
Feb 12, 2026—-$0.19-$0.12+36.8%$43.04M$44.65M
Nov 5, 2025—-$0.16-$0.12+25.0%$44.6M$38.44M
Aug 7, 2025—-$0.18-$0.13+27.8%$39.95M$39.77M
May 8, 2025—-$0.19-$1.44-657.9%$35.44M$37.15M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
4
Buy
3
Hold
1
Sell
12-month analyst target
$1.93
+5.19% versus current price
Based on 8 analyst observations. Targets are estimates, not predictions.
Low target
$1.35
-26.23% vs latest price
Average target
$1.93
+5.19% vs latest price
High target
$2.50
+36.61% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 9, 2027

Next known earnings or reporting date.

EPS estimate-$0.13

Current analyst expectation for the upcoming report.

Revenue estimate$47.45M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score84

Where event reaction would show up first.

AIQ score48/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
8
Average target
$1.93
Target upside
5.19%
Target range
$1.35 - $2.50

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
gurufocus.com · Oct 6, 2026

PacBio (PACB) Partners with TychoBio to Advance RNA Therapy Development Using Full-Length RNA Sequencing

On October 06, 2026, Pacific Biosciences of California Inc (PACB) announced a strategic collaboration with TychoBio to generate comprehensive full-length RNA da

seekingalpha.com · Sep 16, 2026

Pacific Biosciences of California, Inc. (PACB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pacific Biosciences of California, Inc. (PACB) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 4:50 PM EDTCompany...

Open full news and sentiment

PACB Catalysts FAQ

What are the next catalysts for PACB stock?

PACB's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move PACB stock?

Upcoming events that could move PACB include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could PACB's next earnings report affect the stock?

PACB's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive PACB stock higher?

PACB could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt PACB stock?

PACB could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.